Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€104.48
27.09.22
€137.00
07.11.25
-0.23%
15.02.24

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€172.20
27.09.22
€202.00
07.11.25
-19.22%
05.05.24

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€147.46
27.09.22
€262.00
07.11.25
10.40%
15.02.24

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€171.94
26.09.22
€150.00
26.09.23
-15.44%
11.07.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€204.55
24.09.22
-
24.09.23
37.28%
18.05.23

Risky Investment
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€228.00
20.09.22
€270.00
20.09.23
11.84%
21.09.23

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€130.00
19.09.23
-8.59%
20.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€140.00
19.09.23
-4.03%
01.10.22

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€72.15
19.09.22
€90.00
19.09.23
1.37%
01.10.22

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
9.92%
16.09.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€309.00
15.09.22
€550.00
15.09.23
74.76%
16.09.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€319.00
11.09.22
€360.00
27.03.23
1.94%
10.01.23

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€69.37
07.09.22
€100.00
31.12.25
-12.07%
05.05.23

Could be very worthwhile Investment >20% year
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€285.85
07.09.22
€400.00
31.12.25
10.34%
05.05.23

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€312.95
07.09.22
€450.00
31.12.25
24.24%
05.05.23

Could be very worthwhile Investment >20% year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€199.36
07.09.22
€300.00
31.12.24
36.69%
30.09.22

Could be very worthwhile Investment >20% year
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€104.26
07.09.22
-
07.09.23
-2.47%
28.12.22

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€159.16
30.08.22
€180.00
30.08.23
11.21%
31.08.23

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€90.50
24.08.22
€120.00
24.08.23
17.79%
08.05.23

Could be worthwhile Investment >10% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.74
22.08.22
€80.00
22.08.23
8.80%
23.08.23

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.70
21.08.22
-
21.08.23
-21.03%
27.02.23

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€65.08
19.08.22
-
19.08.23
7.28%
20.08.23

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€10.85
16.08.22
-
16.08.23
2.45%
10.11.22

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€167.80
05.08.22
€190.00
05.08.23
-8.34%
06.08.23

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€176.92
03.08.22
€190.00
03.08.23
-6.34%
03.08.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model